KELOID DISEASE: PROSPCETIVE CROSS-SECTIONAL STUDY OF CLINICOEPIDEMIOLOGICAL AND HEALTH RELATED QUALITY OF LIFE AT A TERTIARY CENTER
Keloid disease: clinicoepidemiologic and health related quality of life
Background: Keloid disease and its impact on the quality of life of patients is not frequently documented. The objective of this study was to document the epidemiologic and clinical features of keloid and its impact on the quality of life of patients.
Methodology: A prospective cross-sectional study of 64 adult keloid disease patients was conducted over a one-year period following informed consent and ethical approval at a tertiary centre. Patients were clinically evaluated and quality of life was assessed using the dermatology life quality index (DLQI). Data was analysed using SPSS version 23.0.
Results: The dermatology clinic prevalence of keloid was 11.6%. The mean age of those who had keloid was 34.34 ± 15.15 years and they were 60.9% female. The mean duration and mean age at onset of keloid were 5.98 ± 8.73 and 28.38 ± 13.84 years respectively. The reason for seeking treatment was dislike of the keloid lesions in 65.6%. Symptoms of pain and pruritus were reported in 51.6% and 92.2% respectively. The mean DLQI score was 6.84 ± 4.94. Quality of life was impaired in 92.2% patients and this was a small effect in 40.6%. The only factor which correlated with Quality of life (QOL) impairment was the number of keloids; p=0.021.
Conclusion: Keloid is a disease of the young, has a female preponderance and occur more on the chest and face. Quality of life is negatively affected and patients seek treatment because of embarrassment, dislike for the keloid lesions and the multiplicity of lesions.